Letters

Editor's Note: In the past few months, the case of Forrest M. Mims III has received considerable publicity. Mims, a veteran science writer from Seguin, Texas, was commissioned by Scientific American to write a column called "The Amateur Scientist," but the magazine revoked his assignment when the editors learned that Mims is an evangelical Christian who does not believe in evolution. Mims has accused Scientific American of religious discrimination; the magazine denies the charge. The Opinion

Written byArthur Caplan
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The Opinion section of the Feb. 18, 1991, issue of The Scientist contained an essay by Mims in which he elaborated on his allegations against Scientific American. Accompanying Mims's article was an essay by Arthur L. Caplan, professor of philosophy and director of the Center for Biomedical Ethics at the University of Minnesota in Minneapolis. In his essay, Caplan contended that Scientific American had to deny Mims authorship of the column because the magazine needed to take a stand on what is science and what is not.

After the publication of The Scientist's February 18 issue, many readers reacted to Mims's and Caplan's essays in letters to the editor. These letters were published in the April 29, 1991, issue of The Scientist. Here, Mims and Caplan respond to the readers' letters.

Those who doubt that for some of its adherents Darwinism has evolved into a philosophical dogma that justifies censoring, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies